Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-24

Clinical Trial Update: Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea [Phase 4]

View source ↗

Summary

Phase 4 trial update for azelaic acid foam 15% in papulopustular rosacea has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic Acid Foam 15% (azelaic acid)

Snippet

Sponsor: Clinical Research Center of the Carolinas | Conditions: Rosacea, Papulopustular | Phase 4 | Status: COMPLETED